Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

193 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Recapitulating thyroid cancer histotypes through engineering embryonic stem cells.
Veschi V, Turdo A, Modica C, Verona F, Di Franco S, Gaggianesi M, Tirrò E, Di Bella S, Iacono ML, Pantina VD, Porcelli G, Mangiapane LR, Bianca P, Rizzo A, Sciacca E, Pillitteri I, Vella V, Belfiore A, Bongiorno MR, Pistone G, Memeo L, Colarossi L, Giuffrida D, Colarossi C, Vigneri P, Todaro M, Stassi G. Veschi V, et al. Among authors: giuffrida d. Nat Commun. 2023 Mar 11;14(1):1351. doi: 10.1038/s41467-023-36922-1. Nat Commun. 2023. PMID: 36906579 Free PMC article.
Therapeutic efficacy of platinum/etoposide regimens in the treatment of advanced poorly differentiated neuroendocrine carcinomas of the lung: A retrospective analysis.
Puliafito I, Chillari F, Russo A, Cantale O, Sciacca D, Castorina L, Colarossi C, Franchina T, Vitale MP, Ricciardi GRR, Adamo V, Esposito F, Giuffrida D. Puliafito I, et al. Among authors: giuffrida d. Front Endocrinol (Lausanne). 2023 Jan 30;14:1065599. doi: 10.3389/fendo.2023.1065599. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 36793289 Free PMC article.
Body mass index and baseline platelet count as predictive factors in Merkel cell carcinoma patients treated with avelumab.
Incorvaia L, Dimino A, Algeri L, Brando C, Magrin L, De Luca I, Pedone E, Perez A, Sciacchitano R, Bonasera A, Bazan Russo TD, Li Pomi F, Peri M, Gristina V, Galvano A, Giuffrida D, Fazio I, Toia F, Cordova A, Florena AM, Giordano A, Bazan V, Russo A, Badalamenti G. Incorvaia L, et al. Among authors: giuffrida d. Front Oncol. 2023 Apr 17;13:1141500. doi: 10.3389/fonc.2023.1141500. eCollection 2023. Front Oncol. 2023. PMID: 37139149 Free PMC article.
Editorial: Neuroendocrine tumors: the road to precision medicine.
La Salvia A, Giuffrida D, Modica R. La Salvia A, et al. Among authors: giuffrida d. Front Endocrinol (Lausanne). 2023 Jul 26;14:1253319. doi: 10.3389/fendo.2023.1253319. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37564989 Free PMC article. No abstract available.
MiRNA dysregulation underlying common pathways in type 2 diabetes and cancer development: an Italian Association of Medical Oncology (AIOM)/Italian Association of Medical Diabetologists (AMD)/Italian Society of Diabetology (SID)/Italian Society of Endocrinology (SIE)/Italian Society of Pharmacology (SIF) multidisciplinary critical view.
Natalicchio A, Montagnani M, Gallo M, Marrano N, Faggiano A, Zatelli MC, Mazzilli R, Argentiero A, Danesi R, D'Oronzo S, Fogli S, Giuffrida D, Gori S, Ragni A, Renzelli V, Russo A, Franchina T, Tuveri E, Sciacca L, Monami M, Cirino G, Di Cianni G, Colao A, Avogaro A, Cinieri S, Silvestris N, Giorgino F. Natalicchio A, et al. Among authors: giuffrida d, d oronzo s. ESMO Open. 2023 Jun;8(3):101573. doi: 10.1016/j.esmoop.2023.101573. Epub 2023 May 31. ESMO Open. 2023. PMID: 37263082 Free PMC article. Review.
Assessing the safety and activity of cabozantinib combined with lanreotide in gastroenteropancreatic and thoracic neuroendocrine tumors: rationale and protocol of the phase II LOLA trial.
Corti F, Brizzi MP, Amoroso V, Giuffrida D, Panzuto F, Campana D, Prinzi N, Milione M, Cascella T, Spreafico C, Randon G, Oldani S, Leporati R, Scotto G, Pulice I, Stocchetti BL, Porcu L, Coppa J, Di Bartolomeo M, de Braud F, Pusceddu S. Corti F, et al. Among authors: giuffrida d. BMC Cancer. 2023 Sep 26;23(1):908. doi: 10.1186/s12885-023-11287-2. BMC Cancer. 2023. PMID: 37752423 Free PMC article.
Diabetes management in cancer patients. An Italian Association of Medical Oncology, Italian Association of Medical Diabetologists, Italian Society of Diabetology, Italian Society of Endocrinology and Italian Society of Pharmacology multidisciplinary consensus position paper.
Silvestris N, Franchina T, Gallo M, Argentiero A, Avogaro A, Cirino G, Colao A, Danesi R, Di Cianni G, D'Oronzo S, Faggiano A, Fogli S, Giuffrida D, Gori S, Marrano N, Mazzilli R, Monami M, Montagnani M, Morviducci L, Natalicchio A, Ragni A, Renzelli V, Russo A, Sciacca L, Tuveri E, Zatelli MC, Giorgino F, Cinieri S. Silvestris N, et al. Among authors: giuffrida d. ESMO Open. 2023 Dec;8(6):102062. doi: 10.1016/j.esmoop.2023.102062. Epub 2023 Dec 8. ESMO Open. 2023. PMID: 38070434 Free PMC article. Review.
Endocrine-metabolic assessment checklist for cancer patients treated with immunotherapy: A proposal by the Italian Association of Medical Oncology (AIOM), Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology (SIE) and Italian Society of Pharmacology (SIF) multidisciplinary group.
Zatelli MC, Faggiano A, Argentiero A, Danesi R, D'Oronzo S, Fogli S, Franchina T, Giorgino F, Marrano N, Giuffrida D, Gori S, Marino G, Mazzilli R, Monami M, Montagnani M, Morviducci L, Natalicchio A, Ragni A, Renzelli V, Russo A, Sciacca L, Tuveri E, Aimaretti G, Avogaro A, Candido R, Di Maio M, Silvestris N, Gallo M. Zatelli MC, et al. Among authors: giuffrida d. Cancer Treat Rev. 2024 May;126:102734. doi: 10.1016/j.ctrv.2024.102734. Epub 2024 Apr 3. Cancer Treat Rev. 2024. PMID: 38604051 Free article. Review.
193 results